Etoposide Phosphate

• Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients … Pending
  2024-517295-37-00 Phase III 1 country University Of Cologne
• Chemoimmunotherapy in conjunction with blood-brain-barrier opening in patients with newly diagnosed or relapsed primary central nervous syst… Pending
  2024-519046-79-00 Phase II 1 country Oulu University Hospital
• Glo-BNHL: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma Recruiting
  2024-510575-38-00 Phase II/III 6 countries The University Of Birmingham
• not applicable Recruiting
  2023-508953-16-00 Phase II 1 country Nationwide Childrens Hospital
• CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting
  2023-504999-25-00 Phase III 12 countries Prinses Maxima Centrum voor Kinderoncologie B.V.
• rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma Recruiting
  2024-516078-31-00 Phase II/III 10 countries The University Of Birmingham
• Pembro-CORE pilot Ended
  2022-501306-35-00 Phase II 1 country University Of Cologne
• AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia Ended
  2023-509856-32-00 Phase III 5 countries Universitaetsklinikum Schleswig-Holstein
• Polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (Pola-R-ICE) versus R-ICE alone in second line treatment of diffus… Ended
  2023-508259-38-00 Phase III 3 countries GWT-Tud GmbH
• HD21 Ended
  2024-518022-33-00 Phase III 6 countries University Of Cologne

Showing 1–10 of 10 trials